Impact fact

Sarah has worked with many pharma organizations to devise effective launch strategies that enable innovative therapies to become available for patients.


As the office managing principal of ZS Singapore, Sarah helps pharmaceutical and biotech companies across the APAC region successfully address a range of commercial, marketing and market access issues. 


Sarah is an expert in commercialization and market access, partnering with organizations to ensure assets are well-placed for launch and patient access success. She has recently supported client initiatives such as early asset opportunity assessment, launch readiness, market access and pricing strategy, customer insights and capability development. 

Prior experience

Prior to her move to Singapore, Sarah was a leader in ZS’s European value and access practice, where she supported global pricing and access strategy. She was also involved in the development of ZS innovations including Payer Connect and Payer Live to enable rapid payer research. She has worked with clients across Europe, Asia, the Middle East and Latin America​.


Sarah holds an M.S. in global health policy from Imperial College London, and a master’s degree in biochemistry from Oxford University.